Transcriptional profiling reveals a subset of human breast tumors that retain wt TP53 but display mutant p53‐associated features-Reference-Cited by-同舟云学术

Transcriptional profiling reveals a subset of human breast tumors that retain wt TP53 but display mutant p53‐associated features

Published:2020-06-23 Issue:8 Volume:14 Page:1640-1652
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Benor Gal¹,Fuks Garold¹,Chin Suet‐Feung²,Rueda Oscar M.²,Mukherjee Saptaparna³,Arandkar Sharathchandra³⁴,Aylon Yael³,Caldas Carlos²,Domany Eytan¹,Oren Moshe³^ORCID

Affiliation:

1. Department of Physics of Complex Systems The Weizmann Institute of Science Rehovot Israel

2. Cancer Research UK Cambridge Institute and Department of Oncology Li Ka Shing Centre University of Cambridge Cambridge UK

3. Department of Molecular Cell Biology The Weizmann Institute of Science Rehovot Israel

4. Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) Tata Memorial Centre Kharghar India

Funder

Dr. Miriam and Sheldon G. Adelson Medical Research Foundation

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12736

Reference37 articles.

1. Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms

2. Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features

3. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

4. When mutants gain new powers: news from the mutant p53 field

5. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning analysis of gene expression reveals TP53 Mutant-like AML with wild type TP53 and poor prognosis;Blood Cancer Journal;2024-05-14

2. p53 deficient breast cancer cells reprogram preadipocytes toward tumor-protective immunomodulatory cells;Proceedings of the National Academy of Sciences;2023-12-21

3. Pharmacological reactivation of p53 in the era of precision anticancer medicine;Nature Reviews Clinical Oncology;2023-12-15

4. Integrative bioinformatic analysis of p53 and pathway alterations in two different lung cancer subtypes;Biochemistry and Biophysics Reports;2023-03

5. Machine learning investigation of gene expression datasets revealsTP53mutant-like AML with wild typeTP53and poor prognosis;2023-02-23